Variant report

Variant	esv2759673
Chromosome Location	chr9:16641966-16809203
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1137)
CpG islands
(count:489)
Chromatin interactive
region (count:11)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1137 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:16653619-16654168	HepG2	liver:	n/a	n/a
2	ATF2	chr9:16726542-16727101	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr9:16705170-16705700	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr9:16708535-16709145	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr9:16708465-16709294	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF3	chr9:16704572-16705732	A549	lung:	n/a	n/a
7	ATF3	chr9:16704594-16705717	A549	lung:	n/a	n/a
8	BACH1	chr9:16730241-16730320	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr9:16725246-16725293	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr9:16708624-16709106	H1-hESC	embryonic stem cell:	n/a	n/a
11	BCL3	chr9:16726476-16727092	A549	lung:	n/a	n/a
12	BCL3	chr9:16704567-16705721	A549	lung:	n/a	n/a
13	BCL3	chr9:16726555-16727142	A549	lung:	n/a	n/a
14	BCL3	chr9:16704702-16705796	A549	lung:	n/a	n/a
15	BCL3	chr9:16701219-16701697	A549	lung:	n/a	n/a
16	BHLHE40	chr9:16655674-16655965	GM12878	blood:	n/a	chr9:16655674-16655683 chr9:16655674-16655683 chr9:16655675-16655684
17	BRCA1	chr9:16716591-16716814	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr9:16727204-16727670	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr9:16704795-16705688	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr9:16704971-16705738	ECC-1	luminal epithelium:	n/a	n/a
21	CEBPB	chr9:16726598-16727409	ECC-1	luminal epithelium:	n/a	chr9:16726904-16726915
22	CEBPB	chr9:16726671-16727143	ECC-1	luminal epithelium:	n/a	chr9:16726904-16726915
23	CEBPB	chr9:16682795-16682988	H1-hESC	embryonic stem cell:	n/a	chr9:16682940-16682953
24	CEBPB	chr9:16725984-16727870	Hela-S3	cervix:	n/a	chr9:16726904-16726915
25	CEBPB	chr9:16727518-16727690	A549	lung:	n/a	n/a
26	CEBPB	chr9:16726576-16727752	IMR90	lung:	n/a	chr9:16726904-16726915
27	CEBPB	chr9:16709100-16709447	IMR90	lung:	n/a	n/a
28	CEBPB	chr9:16701129-16701829	A549	lung:	n/a	n/a
29	CEBPB	chr9:16802385-16802655	IMR90	lung:	n/a	n/a
30	CEBPB	chr9:16730233-16730499	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr9:16654727-16655039	IMR90	lung:	n/a	chr9:16654879-16654892
32	CEBPB	chr9:16704727-16705606	A549	lung:	n/a	n/a
33	CEBPB	chr9:16726680-16727042	MCF-7	breast:	n/a	chr9:16726904-16726915
34	CEBPB	chr9:16679425-16679624	IMR90	lung:	n/a	n/a
35	CEBPB	chr9:16727544-16727563	H1-hESC	embryonic stem cell:	n/a	n/a
36	CEBPB	chr9:16704187-16705663	Hela-S3	cervix:	n/a	n/a
37	CEBPB	chr9:16705041-16705616	ECC-1	luminal epithelium:	n/a	n/a
38	CEBPB	chr9:16768769-16769221	H1-hESC	embryonic stem cell:	n/a	n/a
39	CEBPB	chr9:16704646-16705601	IMR90	lung:	n/a	n/a
40	CEBPB	chr9:16716641-16717006	Hela-S3	cervix:	n/a	chr9:16716922-16716933
41	CEBPB	chr9:16704622-16705813	A549	lung:	n/a	n/a
42	CEBPB	chr9:16682881-16683078	A549	lung:	n/a	chr9:16682940-16682953
43	CEBPB	chr9:16697268-16697322	A549	lung:	n/a	n/a
44	CEBPB	chr9:16726736-16727088	HepG2	liver:	n/a	chr9:16726904-16726915
45	CEBPB	chr9:16795267-16795668	IMR90	lung:	n/a	n/a
46	CEBPB	chr9:16710056-16710336	H1-hESC	embryonic stem cell:	n/a	n/a
47	CEBPB	chr9:16704664-16705654	A549	lung:	n/a	n/a
48	CEBPB	chr9:16726699-16727129	A549	lung:	n/a	chr9:16726904-16726915
49	CEBPB	chr9:16701270-16701619	A549	lung:	n/a	n/a
50	CEBPB	chr9:16679433-16679643	A549	lung:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16726860-16726910	AG04450	lung:	fetal
2	chr9:16726860-16726910	AG04450	lung:	fetal
3	chr9:16705212-16705262	HAEpiC	amniotic membrane:	n/a
4	chr9:16729515-16729565	CMK	blood:	n/a
5	chr9:16726860-16726910	AG10803	skin:	n/a
6	chr9:16718892-16718942	HNPCEpiC	eye:	n/a
7	chr9:16729103-16729153	HCPEpiC	choroid plexus:	n/a
8	chr9:16718892-16718942	HEEpiC	esophagus:	n/a
9	chr9:16726860-16726910	BE2_C	brain:	n/a
10	chr9:16726860-16726910	AG09309	skin:	n/a
11	chr9:16726860-16726910	Jurkat	blood:	n/a
12	chr9:16653688-16653738	AG09319	gingival:	n/a
13	chr9:16727830-16727880	H1-hESC	embryonic stem cell:	embryo
14	chr9:16705212-16705262	NHBE	bronchial:	n/a
15	chr9:16653688-16653738	T-47D	breast:	n/a
16	chr9:16705212-16705262	HEK293	kidney:	embryo
17	chr9:16729103-16729153	K562	blood:	n/a
18	chr9:16704404-16704454	GM12878	blood:	n/a
19	chr9:16729515-16729565	PrEC	prostate:	n/a
20	chr9:16653688-16653738	Caco-2	colon:	n/a
21	chr9:16653688-16653738	BJ	skin:	n/a
22	chr9:16653688-16653738	SKMC	muscle:	n/a
23	chr9:16727830-16727880	NHBE	bronchial:	n/a
24	chr9:16729103-16729153	MCF10A-Er-Src	breast:	n/a
25	chr9:16726860-16726910	PFSK-1	brain:	n/a
26	chr9:16705212-16705262	HCT-116	colon:	n/a
27	chr9:16705212-16705262	IMR90	lung:	fetal
28	chr9:16704404-16704454	HNPCEpiC	eye:	n/a
29	chr9:16729103-16729153	HUVEC	blood vessel:	n/a
30	chr9:16718892-16718942	HPAEpiC	pulmonary alveolar:	n/a
31	chr9:16705212-16705262	NHDF-neo	bronchial:	n/a
32	chr9:16718892-16718942	AG09319	gingival:	n/a
33	chr9:16653688-16653738	GM19239	blood:	n/a
34	chr9:16704404-16704454	AG09319	gingival:	n/a
35	chr9:16729515-16729565	ECC-1	luminal epithelium:	n/a
36	chr9:16729103-16729153	HepG2	liver:	n/a
37	chr9:16653688-16653738	NHBE	bronchial:	n/a
38	chr9:16729515-16729565	Hela-S3	cervix:	n/a
39	chr9:16705212-16705262	HCM	heart:	n/a
40	chr9:16729103-16729153	AoSMC	blood vessel:	n/a
41	chr9:16704404-16704454	HEK293	kidney:	embryo
42	chr9:16726860-16726910	CMK	blood:	n/a
43	chr9:16705212-16705262	AG04450	lung:	fetal
44	chr9:16653688-16653738	U87	brain:	n/a
45	chr9:16726860-16726910	HNPCEpiC	eye:	n/a
46	chr9:16726860-16726910	HEEpiC	esophagus:	n/a
47	chr9:16726860-16726910	NHBE	bronchial:	n/a
48	chr9:16653688-16653738	GM12892	blood:	n/a
49	chr9:16727830-16727880	T-47D	breast:	n/a
50	chr9:16704404-16704454	Caco-2	colon:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:52445126..52445753-chr9:16726910..16727745,2	Hela-S3	cervix:
2	chr6:3068763..3069618-chr9:16726993..16727675,2	Hela-S3	cervix:
3	chr9:16191923..16192798-chr9:16648750..16649311,2	MCF-7	breast:
4	chr3:20227400..20228150-chr9:16726744..16727510,2	Hela-S3	cervix:
5	chr11:62609031..62609585-chr9:16704767..16705357,2	Hela-S3	cervix:
6	chr19:41731896..41732688-chr9:16704803..16705712,2	Hela-S3	cervix:
7	chr9:16704972..16705696-chr9:16726846..16727389,2	Hela-S3	cervix:
8	chr9:16653386..16655989-chr9:16657272..16659036,2	MCF-7	breast:
9	chr9:16653386..16655989-chr9:16657272..16659036,2	MCF-7	breast:
10	chr6:2765596..2766255-chr9:16738649..16739454,2	MCF-7	breast:
11	chr7:5569698..5570590-chr9:16726454..16727434,2	Hela-S3	cervix:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf92-4	chr9:16665064-16665173	NONHSAT130290
2	lnc-C9orf92-5	chr9:16775571-16775843	NONHSAT130296
3	lnc-C9orf92-4	chr9:16700841-16700919	NONHSAT130291
4	lnc-C9orf92-4	chr9:16700753-16700983	uc_252_-
5	lnc-CNTLN-2	chr9:16727313-16727522	ENSG00000234779.1
6	lnc-CNTLN-2	chr9:16727029-16727104	ENSG00000234779.1
7	lnc-C9orf92-4	chr9:16714816-16714976	NONHSAT130291
8	lnc-C9orf92-4	chr9:16714816-16714976	NONHSAT130290
9	lnc-CNTLN-6	chr9:16700753-16700983	uc_252_+
10	lnc-CNTLN-2	chr9:16726812-16726953	ENSG00000234779.1

No data

Variant related genes	Relation type
ENSG00000233551	TF binding region
BNC2	TF binding region
ENSG00000234779	TF binding region
ENSG00000233551	CpG island
BNC2	CpG island
ENSG00000234779	CpG island
ENSG00000167601	chromatin interactions
ENSG00000133316	chromatin interactions
ENSG00000075624	chromatin interactions
ENSG00000123358	chromatin interactions
ENSG00000129810	chromatin interactions
ENSG00000272277	chromatin interactions
ENSG00000124535	chromatin interactions
ENSG00000173068	chromatin interactions

Extended variants
information (count: 8175 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:8175 , 50 per page) page: 1 2 3 4 5 6 7 ... 164

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs545176885	chr9:16641996-16641997	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs560233232	chr9:16641997-16641998	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs191434780	chr9:16642014-16642015	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs181128862	chr9:16642052-16642053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs373651878	chr9:16642066-16642067	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs542248780	chr9:16642071-16642072	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs149787812	chr9:16642093-16642094	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs530330520	chr9:16642098-16642099	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs35194031	chr9:16642122-16642123	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs145763063	chr9:16642127-16642128	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs549469252	chr9:16642152-16642153	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs544642014	chr9:16642170-16642171	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs537177583	chr9:16642192-16642193	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs547968901	chr9:16642224-16642225	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs566275640	chr9:16642246-16642247	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs185149891	chr9:16642284-16642285	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs189615230	chr9:16642288-16642289	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs570066037	chr9:16642343-16642344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs537399394	chr9:16642377-16642378	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs183392885	chr9:16642409-16642410	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs577263087	chr9:16642415-16642416	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs376689100	chr9:16642436-16642437	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs538484457	chr9:16642499-16642500	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs553916718	chr9:16642529-16642530	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs572112453	chr9:16642532-16642533	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs542534919	chr9:16642544-16642545	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs556974942	chr9:16642558-16642559	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs575643766	chr9:16642598-16642599	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs543007247	chr9:16642610-16642611	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs187709642	chr9:16642648-16642649	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs564879741	chr9:16642685-16642686	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs115046374	chr9:16642691-16642692	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs111575011	chr9:16642693-16642694	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559916243	chr9:16642919-16642920	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs530268210	chr9:16642963-16642964	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs112054270	chr9:16642974-16642975	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs146557397	chr9:16643048-16643049	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs530971104	chr9:16643057-16643058	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs191743971	chr9:16643093-16643094	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs183650881	chr9:16643146-16643147	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs16934875	chr9:16643147-16643148	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs535134905	chr9:16643160-16643161	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs560453788	chr9:16643174-16643175	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs374702944	chr9:16643197-16643198	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs553164529	chr9:16643219-16643220	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs376385602	chr9:16643255-16643256	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs536001855	chr9:16643273-16643274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs141091175	chr9:16643275-16643276	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs554484668	chr9:16643280-16643281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs34196473	chr9:16643304-16643305	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	21611746	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:3038 , 50 per page) page: 1 2 3 4 5 6 7 ... 61

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16629200-16642200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
2	chr9:16629600-16653600	Weak transcription	HUVEC	blood vessel
3	chr9:16630000-16642400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr9:16636000-16642000	Weak transcription	Duodenum Smooth Muscle	Duodenum
5	chr9:16636400-16642400	Weak transcription	NHDF-Ad	bronchial
6	chr9:16636400-16645800	Weak transcription	Ovary	ovary
7	chr9:16637800-16644600	Weak transcription	Fetal Lung	lung
8	chr9:16637800-16652600	Weak transcription	Fetal Stomach	stomach
9	chr9:16638000-16651200	Weak transcription	HUES64 Cell Line	embryonic stem cell
10	chr9:16638200-16644600	Weak transcription	HUES6 Cell Line	embryonic stem cell
11	chr9:16638400-16642600	Weak transcription	Osteobl	bone
12	chr9:16638400-16644800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr9:16640000-16670800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr9:16640600-16643400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
15	chr9:16640800-16642400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr9:16641000-16642400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr9:16641000-16644800	Weak transcription	HUES48 Cell Line	embryonic stem cell
18	chr9:16641000-16645000	Weak transcription	Rectal Smooth Muscle	rectum
19	chr9:16641000-16645800	Weak transcription	HSMMtube	muscle
20	chr9:16641200-16642600	Weak transcription	NHLF	lung
21	chr9:16641200-16644600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
22	chr9:16641200-16645000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
23	chr9:16641200-16646000	Weak transcription	Muscle Satellite Cultured Cells	--
24	chr9:16641200-16649400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
25	chr9:16641400-16642600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr9:16641400-16651400	Weak transcription	A549	lung
27	chr9:16641600-16642600	Weak transcription	HSMM	muscle
28	chr9:16641800-16642400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr9:16641800-16642800	Enhancers	Colon Smooth Muscle	Colon
30	chr9:16642000-16643000	Enhancers	Duodenum Smooth Muscle	Duodenum
31	chr9:16642200-16643000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr9:16642400-16642600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr9:16642400-16643000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr9:16642400-16643200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr9:16642400-16643200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
36	chr9:16642400-16643200	Enhancers	NHDF-Ad	bronchial
37	chr9:16642600-16643000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr9:16642600-16643000	Enhancers	HSMM	muscle
39	chr9:16642600-16643200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr9:16642600-16643200	Enhancers	NHLF	lung
41	chr9:16642600-16643400	Enhancers	Osteobl	bone
42	chr9:16642800-16644200	Weak transcription	Colon Smooth Muscle	Colon
43	chr9:16643000-16643200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr9:16643000-16644800	Weak transcription	Duodenum Smooth Muscle	Duodenum
45	chr9:16643000-16645000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr9:16643000-16645800	Weak transcription	HSMM	muscle
47	chr9:16643000-16651800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr9:16643200-16646200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr9:16643200-16646200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr9:16643200-16651400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links